DaVita (DVA) Tops Q1 EPS by 9c

DaVita (NYSE: DVA) reported Q1 EPS of $1.02, $0.09 better than the analyst estimate of $0.93. Revenue for the quarter came in at $2.85 billion versus the consensus estimate of $2.78 billion.

Outlook

The following forward-looking measures and the underlying assumptions involve significant risks and uncertainties, including those described herein, and actual results may vary significantly from these current forward-looking measures. The guidance below does not include the impact of currency fluctuations.

• We still expect our Kidney Care consolidated operating income for 2018 to be in the range of $1.5 billion to $1.6 billion.
• We still expect our operating cash flow from continuing operations for 2018 to be in the range of $1.4 billion to $1.6 billion.
• We still expect our 2018 effective tax rate attributable to DaVita Inc. to be approximately 26.5% to 27.5%.

For earnings history and earnings-related data on DaVita (DVA) click here.

You May Also Be Interested In

• Helen of Troy (HELE) Tops Q1 EPS by 22c, Beats on Revenue; Offers FY Guidance
• Nvidia is up just 3% YTD while SOX surges 82% — what’s holding it back?
• Alibaba rallies 12% after report of narrowing losses sparks pre-earnings optimism